Upstream Bio, Inc. (UPB)
1.59
-0.41
(-20.50%)
USD |
NASDAQ |
Nov 20, 16:00
1.62
+0.03
(+1.89%)
After-Hours: 20:00
Upstream Bio Price to Book Value : 0.3725 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.3725 |
| November 19, 2026 | 0.4685 |
| November 18, 2026 | 0.4873 |
| November 17, 2026 | 0.4919 |
| November 16, 2026 | 0.5037 |
| November 13, 2026 | 0.6512 |
| November 12, 2026 | 0.67 |
| November 11, 2026 | 0.7496 |
| November 10, 2026 | 0.7918 |
| November 09, 2026 | 0.8387 |
| November 06, 2026 | 0.7567 |
| November 05, 2026 | 0.752 |
| November 04, 2026 | 0.8668 |
| November 03, 2026 | 0.7941 |
| November 02, 2026 | 0.7848 |
| October 30, 2026 | 0.7988 |
| October 29, 2026 | 0.766 |
| October 28, 2026 | 0.6981 |
| October 27, 2026 | 0.6536 |
| October 26, 2026 | 0.6442 |
| October 23, 2026 | 0.6419 |
| October 22, 2026 | 0.7004 |
| October 21, 2026 | 0.6559 |
| October 20, 2026 | 0.6606 |
| October 19, 2026 | 0.6559 |
| Date | Value |
|---|---|
| October 16, 2026 | 0.6466 |
| October 15, 2026 | 0.7895 |
| October 14, 2026 | 0.8012 |
| October 13, 2026 | 0.8316 |
| October 12, 2026 | 0.9769 |
| October 09, 2026 | 1.101 |
| October 08, 2026 | 1.066 |
| October 07, 2026 | 1.080 |
| October 06, 2026 | 1.075 |
| October 05, 2026 | 1.136 |
| October 02, 2026 | 1.181 |
| October 01, 2026 | 1.181 |
| September 30, 2026 | 1.235 |
| September 29, 2026 | 1.049 |
| September 28, 2026 | 1.071 |
| September 25, 2026 | 1.084 |
| September 24, 2026 | 1.045 |
| September 23, 2026 | 1.049 |
| September 22, 2026 | 1.110 |
| September 21, 2026 | 1.084 |
| September 18, 2026 | 1.079 |
| September 17, 2026 | 1.073 |
| September 16, 2026 | 1.077 |
| September 15, 2026 | 1.108 |
| September 14, 2026 | 1.174 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| PS Ratio | 30.18 |
| PEG Ratio | -0.0166 |
| Price | 1.59 |
| Earnings Yield | -189.5% |
| Market Cap | 87.15M |
| PEGY Ratio | -0.0166 |